News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Frederic C. Kass, MD

Advertisement

Articles by Frederic C. Kass, MD

Dr. Frederic C. Kass on the Importance of Genetic Counseling in Oncology

ByFrederic C. Kass, MD
August 27th 2015

Frederic C. Kass, MD, discusses the importance of genetic counseling in oncology.

Advertisement

Latest Updated Articles

  • Dr. Frederic C. Kass on the Importance of Genetic Counseling in Oncology
    Dr. Frederic C. Kass on the Importance of Genetic Counseling in Oncology

    Published: August 27th 2015 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Real, Placebo Acupuncture Improve Cognitive Outcomes in Breast Cancer Survivors

2

Opinion: CAR T-Cell Therapy Shows Promise in Gastric and GEJ Cancers

3

FDA OKs Subcutaneous Amivantamab Across All NSCLC Indications

4

1L Giredestrant Yields Improved IDFS vs ET in ER+/HER2– Breast Cancer

5

Maintenance Tucatinib/HP Improves PFS Post 2-Year Mark in HER2+ mBC

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us